Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Magnesium orotate in severe congestive heart failure (MACH).

Stepura OB, Martynow AI.

Int J Cardiol. 2009 May 1;134(1):145-7. Erratum in: Int J Cardiol. 2009 May 1;134(1):144. Corrected and republished in: Int J Cardiol. 2009 Jan 9;131(2):293-5.

PMID:
19367681
2.

Magnesium orotate in severe congestive heart failure (MACH).

Stepura OB, Martynow AI.

Int J Cardiol. 2009 Jan 9;131(2):293-5. doi: 10.1016/j.ijcard.2007.11.022. Epub 2008 Feb 20.

PMID:
18281113
3.

Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure.

MacIver J, Rao V, Delgado DH, Desai N, Ivanov J, Abbey S, Ross HJ.

J Heart Lung Transplant. 2008 Sep;27(9):1002-7. doi: 10.1016/j.healun.2008.06.002. Epub 2008 Jul 26.

PMID:
18765193
4.

Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.

Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R; FUSION II Investigators.

Circ Heart Fail. 2008 May;1(1):9-16. doi: 10.1161/CIRCHEARTFAILURE.108.767483.

5.

Assessment of treatment with orotate magnesium in early postoperative period of patients with cardiac insufficiency and coronary artery by-pass grafts (ATOMIC).

Branea I, Gaiţă D, Drăgulescu I, Socoteanu I, Luca C, Mancaş S, Drăgan S, Iurciuc M, Velimirovici D, Gaşpar M, Fluture A, Ionac A, Deutsch P, Pescariu S, Petrescu L, Branea H, Mut B, Dină C, Crâsnic M, Sarău CA.

Rom J Intern Med. 1999 Jul-Sep;37(3):287-96.

PMID:
15532307
6.

[New approaches to the treatment of patients with idiopathic mitral valve prolapse].

Martynov AI, Stepura OB, Shekhter AB, Mel'nik OO, Pak LS, Ushakova TI.

Ter Arkh. 2000;72(9):67-70. Russian.

PMID:
11076423
7.

Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.

Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5.

8.

Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.

Frasure-Smith N, Lespérance F, Habra M, Talajic M, Khairy P, Dorian P, Roy D; Atrial Fibrillation and Congestive Heart Failure Investigators.

Circulation. 2009 Jul 14;120(2):134-40, 3p following 140. doi: 10.1161/CIRCULATIONAHA.109.851675. Epub 2009 Jun 29.

9.

Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure.

Cohen N, Alon I, Almoznino-Sarafian D, Zaidenstein R, Weissgarten J, Gorelik O, Berman S, Modai D, Golik A.

Clin Cardiol. 2000 Jun;23(6):433-6.

10.

Prevalence of Cheyne-Stokes respiration in modern treated congestive heart failure.

Hagenah G, Beil D.

Sleep Breath. 2009 May;13(2):181-5. doi: 10.1007/s11325-008-0218-2. Epub 2008 Sep 13.

PMID:
18791759
13.
14.

Magnesium orotate--experimental and clinical evidence.

Classen HG.

Rom J Intern Med. 2004;42(3):491-501. Review.

PMID:
16366126
15.

Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database.

Khush KK, Tasissa G, Butler J, McGlothlin D, De Marco T; ESCAPE Investigators.

Am Heart J. 2009 Jun;157(6):1026-34. doi: 10.1016/j.ahj.2009.02.022. Epub 2009 Apr 23.

PMID:
19464413
18.

Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.

Güder G, Frantz S, Bauersachs J, Allolio B, Wanner C, Koller MT, Ertl G, Angermann CE, Störk S.

Circ Heart Fail. 2009 Nov;2(6):563-71. doi: 10.1161/CIRCHEARTFAILURE.108.825059. Epub 2009 Sep 24.

19.

Effects of magnesium orotate on exercise tolerance in patients with coronary heart disease.

Geiss KR, Stergiou N, Jester, Neuenfeld HU, Jester HG.

Cardiovasc Drugs Ther. 1998 Sep;12 Suppl 2:153-6.

PMID:
9794089
20.

[Long-term sustained low efficiency dialysis in eight patients with class IV NYHA heart failure resistant to high-dose diuretic treatment].

Violi F, Nacca RG, Iengo G, Iorio L.

G Ital Nefrol. 2009 Jul-Aug;26 Suppl 46:50-2. Italian.

PMID:
19644818

Supplemental Content

Support Center